Neuro-immune crosstalk favouring CRC progression and dissemination KU Leuven
Colorectal cancer (CRC) accounts for approximately 10% of all annually diagnosed cancers and cancer-related deaths worldwide. Nowadays, with continuing diagnostic progress also in developing countries, the incidence of CRC worldwide is predicted to increase to 2·5 million new cases in 2035. Furthermore, although innovative technologies have had a significant impact on the diagnosis and therapy of CRC, patients with advanced disease still have ...